News

Amgen has said the deal with Galapagos could provide it with promising lead candidates for Amgen’s discovery programs over the next two years. Under the terms of the

Exelixis submitted an Investigational New Drug application (IND) for XL518 to the FDA on December 20, 2006. MEK is a key component of a pathway frequently activated in

Lupin Pharmaceuticals, a US subsidiary of Indian-based Lupin Limited, said that final approval is expected upon the expiration of the first abbreviated new drug application filer’s 180-day marketing

The agreement gives Schering-Plough exclusive licence rights to develop, market and distribute the grass pollen allergy drug Grazax, as well as treatments for house dust mite allergy and

The study also confirmed the excellent safety and tolerability profile of DP-b99, according to the Israel-based biopharmaceutical company. There was a significant two-fold increase in the number of

The FDA has determined the Ranbaxy formulations to be bioequivalent and have the same therapeutic effect as Tenormin. Atenolol is indicated in the management of hypertension, which may

The US subsidiary of Japanese pharmaceutical company Daiichi Sankyo said that, if approved, WelChol will be the first LDL cholesterol-lowering medication also indicated for improving glycemic control. Clinical

However, the approval is subject to certain conditions requested by the FDA. Wyeth currently has problems at its manufacturing plant in Guayama, Puerto Rico, where Pristiq will be

The FDA issued this tentative approval because Exforge has met all the required standards for safety, efficacy and manufacturing quality. Exforge is expected to be available to patients